Singapore · 
Who invested in Albatroz Therapeutics?
Albatroz Therapeutics's investors include Seeds Capital.
Singapore · Seed startup
Who invested in Albatroz Therapeutics
Funding summaryUpdated 26 Oct 2026
$3.0Mraised across 1 round since 2023, from 1 source
- Latest round
- Seed, $3.0MApr 2023
- Investors
- 1
The rounds
- Apr 2023
Founders and team
From Albatroz Therapeutics's own website: 2 founders, 3 on the team.
Frederic BardCEO & Scientific Co-Founder
Guy HeathersCBO & Business Co-Founder
- Christopher TanChief Financial Officer
- Cheng-I WangHead of Antibody Development
- Kristina RutkuteDirector, Business Development
AdvisersAndreas WallnoeferFlorian SchusterRoberto Iacone
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Albatroz Therapeutics
How much has Albatroz Therapeutics raised?
Albatroz Therapeutics has raised $3.0M across 1 round since 2023.
When did Albatroz Therapeutics last raise?
Albatroz Therapeutics's most recent round was a Seed of $3.0M in Apr 2023.
What was Albatroz Therapeutics's biggest round?
Its most recent round, $3.0M in Apr 2023, is also its largest on record.
Who backed Albatroz Therapeutics first?
Albatroz Therapeutics's first round on record, in Apr 2023, was backed by Seeds Capital.
What stage is Albatroz Therapeutics at?
Albatroz Therapeutics's latest named round is a Seed, in Apr 2023.
Where is Albatroz Therapeutics based?
Albatroz Therapeutics is based in Singapore.
Companies like Albatroz Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.